1Hadi R, Saunders V, Utkina O,et al.Review of patients with peritoneal malignancy treated with peritonectomy and heated intraperitoneal chemotherapy[J].ANZ J Surg, 2006,76(3) : 156.
2Alberts DS, Liu PY, Hannigan EV, et al.Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous eisplatin plus intravenous cyclophosphamide for stage Ⅲ ovarian caneer[J].N Engl J Med, 1996,335(26): 1950.
3Link KH, Roitman M, Holtappels M, et al.Intraperitoneal chemotherapy with mitoxantrone in malignant aseites[J].Surg Oncol Clin N Am, 2003,12(3) : 865.
4Markman M, Bundy BN, Alberts DS ,et al.Phase Ⅲ trial of standarddose intravenous cisplatin plus paclitaxel vdrsus moderately highdose carboplatin followed by intravenous paclitaxel and intraperitoneal eisplatin in small-volume stage Ⅲ ovarian carcinoma:an in tergroup study of the Gynecologic Oncology Group, Southwestern Ontology Group, and Eastern Cooperative Oneology Group[J].J Clin Oncol,2001,19(4) : 1001.
5Armstrong DK, Bundy B, Wenzel L,et al. Intraperitoneal cisplatin and paclitaxel in ovarian caneer[J].N Engl J Med,2006,354(1):34.
6Fujiwara K, Markman M, Morgan M, et al.Intraperitoneal carboplatinbased chemotherapy for epithelial ovarian caneer[J].Gynecol Oncol, 2005,97(1) : 10.
7Hamilton CA, Berek JS.Intraperitoneal chemotherapy for ovarian cancer[J].CurrOp in Oncol,2006,18(5) :507.
9Makhija S,Leitao M ,Sabbatini P,et al.Complications associated with intraperitoneal chemotherapy catheters[J].Gynecol Oncol,2001,81(1):77.
10Walker JL,Armstrong DK,Huang HQ,et al.Intraperitoneal catheter outcomes in a phase Ⅲ trial of intravenous versus intraperitoneal chemotherapy in op timal stage Ⅲ ovarian and primary peritoneal cancer:a Gynecologic Oncology Group study[J]. Gynecol Oncol, 2006,100 (1) :27.
